Aura Biosciences, Inc. is a clinical-stage oncology company, which engages in developing a novel technology platform based on virus-like drug conjugates (VDCs) to target and destroy cancer cells selectively while activating the immune system to create long lasting anti-tumor immunity. The firm's product candidate belzupacap sarotalocan (AU-011) is in Phase 2 development for the first line treatment of choroidal melanoma, a vision and life-threatening form of eye cancer where standard of care radioactive treatments leave patients with major vision loss and severe comorbidities. The was founded by Elisabet de los Pinos in 2007 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
106
Frequently Asked Questions
What is Market Cap of Aura Biosciences Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Aura Biosciences Inc market cap is $401.92M.
What is the 52-week high for Aura Biosciences Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Aura Biosciences Inc 52 week high is $12.38 as of September 10, 2025.
What is the 52-week low for Aura Biosciences Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Aura Biosciences Inc 52 week low is $4.35 as of September 10, 2025.
What is Aura Biosciences Inc stock price today?
Aura Biosciences Inc stock price today is $6.46.
What was Aura Biosciences Inc stock price yesterday?
Aura Biosciences Inc stock price yesterday was $6.47.
What is the PE ratio of Aura Biosciences Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Aura Biosciences Inc’s P/E ratio is -3.31.
What is the Price-to-Book ratio of Aura Biosciences Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Aura Biosciences Inc P/B ratio is 2.2997.
What is the 50-day moving average of Aura Biosciences Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Aura Biosciences Inc 50-day moving average is $6.63.
